Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Amivantamab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Auburn, California
This trial is testing a drug called amivantamab-vmjw in patients with a specific type of lung cancer that has extra copies of the MET gene. The drug aims to reduce the extra
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.